insights_auto
Why is DMYD-B up 2.34%?
Dive Deeperchevron_right
DMYD-B:STO
Diamyd Medical AB
SEK 0.96
arrow_upward
+2.34%(+0.022) 1D
10-р сарын 8, 09:21:09 (GMT+2) · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMYD-B...
Open
SEK 0.95
High
SEK 0.99
Low
SEK 0.93
Mkt. cap
145.19 сая
Avg. vol.
732.10 мян
Volume
66.09 мян
52-wk high
SEK 17.88
52-wk low
SEK 0.90
EPS
-SEK 1.98
Shares outstanding
134.00 сая
No. of employees
44
Open
SEK 0.95
High
SEK 0.99
Low
SEK 0.93
Mkt. cap
145.19 сая
Avg. vol.
732.10 мян
Volume
66.09 мян
52-wk high
SEK 17.88
52-wk low
SEK 0.90
EPS
-SEK 1.98
Shares outstanding
134.00 сая
No. of employees
44
News stories
From web sources and news partners
BigGo Finance
·
36 минутын өмнө
Metaplanet's Bitcoin Contribution Valued at $179 Million as U.S. Gaming Firm Seeks Shareholder Approval
Stocktwits
·
48 минутын өмнө
Bonds To Outperform Stocks? BofA’s Savita Subramanian Says S&P 500 Returns May Fall Below 5% Over 10 Years
Simply Wall Street
·
55 минутын өмнө
European Expansion Might Change The Case For Investing In Xometry (XMTR)
Yahoo Finance
·
1 цагийн өмнө
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB